Crossmark

Regulatory Capture in Pharmaceutical Policy Making: The Case of National Medicine Agencies Related to the EU Falsified Medicines Directive

Crossref DOI link: https://doi.org/10.1007/s40290-019-00277-0

Published Online: 2019-04-02

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Borup, Rasmus

Traulsen, Janine Morgall https://orcid.org/0000-0001-8927-4478
Kaae, Susanne https://orcid.org/0000-0002-8187-365X
License Information

Text and Data Mining valid from 2019-04-02
More Information

Article History

First Online: 2 April 2019

Compliance with Ethical Standards

:

: This research did not receive any specific grants from funding agencies in the public, commercial, or not-for-profit sectors.

: Rasmus Borup, Janine Morgall Traulsen and Susanne Kaae have no conflicts of interest to declare.

: The project was reported to the Danish Data Protection Agency and data were handled in accordance with agency guidelines. No ethical approval was required in Denmark or the Netherlands for conducting interviews.